France· FR:65607585
BEOVU 120 mg/ml, solution injectable en seringue préremplie
A brolucizumab product containing brolucizumab, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Brolucizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC S01LA06 (brolucizumab), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Brolucizumab · ATC S01LA06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BROLUCIZUMAB
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- S01LA06
- ATC class
- Brolucizumab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301983841 seringue(s) préremplie(s) en verre de 0,165 mlEUR 348.68
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brolucizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeovu 120 mg/mlNovartis Europharm
- CzechiaBEOVUNovartis Europharm Limited, Dublin
- IcelandBeovuNovartis Europharm Limited*
- SwedenBeovu 120 mg/ml Injektionsvätska, lösningNovartis Europharm Limited
- IrelandBeovu 120 mg/ml solution for injection in pre-filled syringeNovartis Europharm Limited
- PolandBeovuNovartis Europharm Limited
- SwitzerlandBeovu
- NetherlandsBeovu 120 mg/ml, oplossing voor injectieNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beovu
- Liechtenstein · Beovu
- Norway · Beovu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a42f04e-41ca-439e-a16c-d81b43d83a74 GET /v1/drugs/4a42f04e-41ca-439e-a16c-d81b43d83a74?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65607585",
"date_amm": "2020-02-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1417",
"substance": "BROLUCIZUMAB",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intravitréenne",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about brolucizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.